Search Site

Search form

Investors

VRTX NASDAQ 100Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.

Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. Read more about our global locations.

Our Investor Relations team participates in many investor events and presentations throughout the year, and we invite you to sign up for our email and news alerts and listen to archived and live presentations.

Latest Press Releases:

See more press releases

To receive Vertex's press releases by email, please sign up for Email & News Alerts.

With the recent progress across our research and development programs in cystic fibrosis, we have established a clear path for the future of our company.

– Jeffrey Leiden, M.D., Ph.D., Chairman, President and Chief Executive Officer of Vertex.

 


Last updated: Monday, November 10, 2014 - 17:33